303
Participants
Start Date
April 30, 2006
Primary Completion Date
July 31, 2008
Study Completion Date
August 31, 2014
exenatide, long acting release
exenatide
Research Site 053, Rochester
Research Site 152, Philadelphia
Research Site 123, Winston-Salem
Research Site 002, Durham
Research Site 587, Greer
Research Site 057, Miami
Research Site 099, Lexington
Research Site 557, Marion
Research Site 405, Cincinnati
Research Site 149, Indianapolis
Research Site 017, Detroit
Research Site 224, Minneapolis
Research Site 023, Butte
Research Site 312, St Louis
Research Site 015, Dallas
Research Site 009, San Antonio
Research Site 182, Encino
Research Site 171, La Jolla
Research Site 518, San Diego
Research Site 024, Walnut Creek
Research Site 231, Portland
Research Site 108, Olympia
Research Site, Colorado Springs
Research Site, Chicago
Research Site, Toronto
Lead Sponsor
AstraZeneca
INDUSTRY